P1.17.71 Treatment Changes Over 12 Months of Observation for ALK and EGFR-Positive NSCLC - Results From an Real-World Study
Back to course
Asset Subtitle
Upal Basu Roy
Meta Tag
Speaker Upal Basu Roy
Topic Global Health, Health Services, and Health Economics
Powered By